Open AccessImpact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment
Author(s) -
Hernandez Jaime E.,
Grainger Joanne,
Simonsen Lone,
Collis Phil,
Edelman Laurel,
Sheridan William P.
Publication year - 2012
Publication title -
influenza and other respiratory viruses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.743
H-Index - 57
eISSN - 1750-2659
pISSN - 1750-2640
DOI - 10.1111/j.1750-2659.2011.00303.x
Subject(s) - neuraminidase , pandemic , medicine , neuraminidase inhibitor , oseltamivir , diagnostic test , human mortality from h5n1 , influenza a virus , influenza pandemic , virology , covid-19 , pediatrics , virus , disease , infectious disease (medical specialty)
Please cite this paper as: Hernandez et al. (2012) Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment. Influenza and Other Respiratory Viruses 6(5), 305–308. Analysis of a US hospitalization database demonstrated that more influenza patients were hospitalized and the age distribution of hospitalizations was younger during the 2009 (H1N1) influenza A pandemic compared with the three previous influenza seasons. The duration of hospital stay remained stable in all four seasons. A higher proportion of patients was treated with antivirals ( P < 0·0001), comprised almost entirely of neuraminidase inhibitors, and the proportion was highest in those with influenza confirmed by diagnostic testing ( P < 0·0001). Approximately one‐third remained untreated. Young children had the lowest rate of neuraminidase‐inhibitor treatment during the 2009 pandemic ( P < 0·05).